rs147953784
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001173990.3(TMEM216):c.35-17C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00571 in 1,530,872 control chromosomes in the GnomAD database, including 71 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0051 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0058 ( 65 hom. )
Consequence
TMEM216
NM_001173990.3 intron
NM_001173990.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.113
Publications
1 publications found
Genes affected
TMEM216 (HGNC:25018): (transmembrane protein 216) This locus encodes a transmembrane domain-containing protein. Mutations at this locus have been associated with Meckel-Gruber Syndrome Type 2, and Joubert Syndrome 2, also known as Cerebello-oculorenal Syndrome 2. [provided by RefSeq, Aug 2010]
TMEM216 Gene-Disease associations (from GenCC):
- Joubert syndrome 2Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Joubert syndrome with oculorenal defectInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- Meckel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- orofaciodigital syndrome type 6Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 11-61393214-C-T is Benign according to our data. Variant chr11-61393214-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257597.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00513 (782/152312) while in subpopulation SAS AF = 0.024 (116/4830). AF 95% confidence interval is 0.0205. There are 6 homozygotes in GnomAd4. There are 419 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TMEM216 | NM_001173990.3 | c.35-17C>T | intron_variant | Intron 1 of 4 | ENST00000515837.7 | NP_001167461.1 | ||
| TMEM216 | NM_001173991.3 | c.35-17C>T | intron_variant | Intron 1 of 4 | NP_001167462.1 | |||
| TMEM216 | NM_016499.6 | c.-149-17C>T | intron_variant | Intron 1 of 4 | NP_057583.2 | |||
| TMEM216 | NM_001330285.2 | c.-149-17C>T | intron_variant | Intron 1 of 4 | NP_001317214.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00514 AC: 783AN: 152194Hom.: 6 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
783
AN:
152194
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00785 AC: 1067AN: 135982 AF XY: 0.00933 show subpopulations
GnomAD2 exomes
AF:
AC:
1067
AN:
135982
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00577 AC: 7956AN: 1378560Hom.: 65 Cov.: 28 AF XY: 0.00647 AC XY: 4400AN XY: 680562 show subpopulations
GnomAD4 exome
AF:
AC:
7956
AN:
1378560
Hom.:
Cov.:
28
AF XY:
AC XY:
4400
AN XY:
680562
show subpopulations
African (AFR)
AF:
AC:
24
AN:
31478
American (AMR)
AF:
AC:
162
AN:
35600
Ashkenazi Jewish (ASJ)
AF:
AC:
61
AN:
25074
East Asian (EAS)
AF:
AC:
8
AN:
35682
South Asian (SAS)
AF:
AC:
1750
AN:
79036
European-Finnish (FIN)
AF:
AC:
109
AN:
33858
Middle Eastern (MID)
AF:
AC:
192
AN:
5676
European-Non Finnish (NFE)
AF:
AC:
5289
AN:
1074446
Other (OTH)
AF:
AC:
361
AN:
57710
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
393
785
1178
1570
1963
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
190
380
570
760
950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00513 AC: 782AN: 152312Hom.: 6 Cov.: 32 AF XY: 0.00563 AC XY: 419AN XY: 74480 show subpopulations
GnomAD4 genome
AF:
AC:
782
AN:
152312
Hom.:
Cov.:
32
AF XY:
AC XY:
419
AN XY:
74480
show subpopulations
African (AFR)
AF:
AC:
30
AN:
41564
American (AMR)
AF:
AC:
117
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
9
AN:
3470
East Asian (EAS)
AF:
AC:
3
AN:
5180
South Asian (SAS)
AF:
AC:
116
AN:
4830
European-Finnish (FIN)
AF:
AC:
30
AN:
10618
Middle Eastern (MID)
AF:
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
AC:
451
AN:
68026
Other (OTH)
AF:
AC:
14
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
37
74
112
149
186
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
24
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Mar 28, 2016
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:3
May 08, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Joubert syndrome 2 Benign:2
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Dec 19, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Meckel syndrome, type 2 Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Joubert syndrome Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.